greeksoup/ stock research

Privia Health Group (PRVA) FY2020 results: revenue $817 million, up 3.9% on the year

Privia Health Group, Inc. (PRVA) reported revenue of $817 million for fiscal 2020, the year ended 31 December 2020, up 3.9% on the year before. Net income was $31 million, up 279.0%, and diluted earnings per share $0.33. The figures are the company's own, from the 10-K it filed with the SEC on 25 March 2022.

Revenue
$817 million
+3.9% on the year
FY2019FY2020
Operating margin
3.1%
2.0% a year earlier
FY2019FY2020
Net income
$31 million
+279.0% on the year
FY2019FY2020
Diluted EPS
$0.33
+266.7% on the year
FY2019FY2020

this yearthe year beforeHover a bar for its figure.

The year in brief

Income statement (profit and loss)

$ millionFY2020FY2019On the yearLast 8 years
Revenue817786+3.9%
Operating income25.416.1+58.0%
Operating margin3.1%2.0%
Interest expense1.94.0-52.5%
Pre-tax income23.59.2+156.4%
Income tax-7.41.2
Effective tax rate-31.7%13.2%
Net income31.28.2+279.0%
Net margin3.8%1.0%
Diluted EPS$0.33$0.09+266.7%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2020FY2019On the yearLast 8 years
Operating cash flow38.924.4+59.7%
Capital expenditure0.45.7-93.3%
Free cash flow38.518.6+106.5%
Free cash flow margin4.7%2.4%
Cash from investing-0.4-5.7
Cash from financing-0.8-10.9
Depreciation and amortisation1.81.4+29.2%
Share-based compensation0.50.2+133.8%
Diluted shares, weighted96m96m+0.0%
Shares outstanding at period end96mn/a

Balance sheet

$ millionFY2020FY2019On the yearLast 8 years
Shareholders' equity147107+36.6%
Non-controlling interest-3.1n/a
Debt32.8n/a
Operating lease liabilities0.0n/a
Other liabilities153n/a
Total liabilities and equity329n/a
Fixed assets4.8n/a
Goodwill119n/a
Intangible assets6.0n/a
Cash and equivalents84.646.9+80.5%
Receivables99.1n/a
Other assets15.8n/a
Total assets329n/a

10-K for the year ended 31 December 2020, filed 25 March 2022: the filing.